Recent Faculty Research Awards and Grants
Ethan Dmitrovsky, M.D., Professor of Pharmacology and Toxicology and of Medicine, has been awarded a one year Samuel Waxman Cancer Research Foundation grant (7/1/13-6/30/14), entitled: Targeting Chromosomal Instability in Lung Cancer.
Alan Eastman, Ph.D., Professor of Pharmacology and Toxicology, has been awarded a three year Leukemia & Lymphoma Society research grant (10/1/12-9/30/15) entitled: Enhancing the Efficacy of BCL2 Inhibitors in Chronic Lymphocytic Leukemia.
Dr. Eastman was also awarded an NIH R01 competitive renewal from the National Cancer Institute (4/1/13-3/31/18) entitled: Mechanisms of Sensitivity to Cell Cycle Checkpoint Kinase Inhibitors.
Manabu Kurokawa, Ph.D., Assistant Professor of Pharmacology and Toxicology, has been awarded an NIH R00 grant from the National Cancer Institute (9/1/12-8/31/15) entitled: Molecular Mechanisms of Chemoresistance in Breast Cancer.
Carmen Marsit, Ph.D., Associate Professor of Pharmacology and Toxicology and of Community and Family Medicine, received an NIH R01 award from the National Institute of Mental Health (9/6/11-6/30/16) entitled: Epigenetics in Neurodevelopment and Mental Health.
Dr. Marsit also received an NIH R01 award from the Institute of Environmental Health Sciences (9/1/13-4/30/18) entitled: Environment, Imprinting & Neurodevelopment.
Michael Sporn, M.D., Oscar M. Cohn '34 Professor in Residence of Pharmacology and Toxicology and of Medicine, has renewed a two year contract with REATA Pharmaceuticals (8/01/2012-7/31/2014), entitled: Sponsored Research Agreement on Triterpenoids.
Dr. Sporn and Karen Liby, Ph.D., Research Associate Professor of Pharmacology and Toxicology and of Medicine, were jointly awarded a sixth year renewable grant from the Breast Cancer Foundation (10/1/13-9/30/14) entitled: Chemoprevention of Experimental Estrogen Receptor - Negative Breast Cancer.